An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

Also called NCT04756180

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 248 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04756180
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04756180. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2019-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.
Condition
Hypertriglyceridemia
Intervention (Drug)
Omega-3-acid ethyl ester or Placebo
Lead sponsor
Abbott (class: industry)

Record details

Record id
cardio:ct-nct04756180
Content hash
a460c4d82f9c3e7d0bb82a4560f12c00e875b4991ee5d561d64b14cb685641ac